These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 17105930)

  • 41. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
    Monti JM; Jantos H
    Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Compromised circadian function in Parkinson's disease: enucleation augments disease severity in the unilateral model.
    Willis GL; Kelly AM; Kennedy GA
    Behav Brain Res; 2008 Nov; 193(1):37-47. PubMed ID: 18547659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tolerance to some behavioural effects of lisuride, a dopamine receptor agonist, and reverse tolerance to others, after repeated administration.
    Carruba MO; Ricciardi S; Chiesara E; Spano PF; Mantegazza P
    Neuropharmacology; 1985 Mar; 24(3):199-206. PubMed ID: 4039419
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lisuride prevents learning and memory impairment and attenuates the increase in extracellular dopamine induced by transient global cerebral ischemia in rats.
    Caldwell MA; Reymann JM; Allain H; Leonard BE; Bentué-Ferrer D
    Brain Res; 1997 Oct; 771(2):305-18. PubMed ID: 9401751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopamine receptor agonists and levodopa and inducing psychosis-like behavior in the MPTP primate model of Parkinson disease.
    Fox SH; Visanji NP; Johnston TH; Gomez-Ramirez J; Voon V; Brotchie JM
    Arch Neurol; 2006 Sep; 63(9):1343-4. PubMed ID: 16966523
    [No Abstract]   [Full Text] [Related]  

  • 46. Transdermal lisuride delivery in the treatment of Parkinson's disease.
    Woitalla D; Müller T; Benz S; Horowski R; Przuntek H
    J Neural Transm Suppl; 2004; (68):89-95. PubMed ID: 15354393
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Action of lisuride on reserpine-induced muscular rigidity in rats after local application into the striatum, ventricular space or the spinal subarachnoid space.
    Flosbach CW; Bräutigam M; Dreesen R; Herken H
    Arzneimittelforschung; 1982; 32(5):488-91. PubMed ID: 7201824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Antagonism of Corticotropin-Releasing Factor Receptor-1 in Brain Suppress Stress-Induced Propofol Self-Administration in Rats.
    Dong Z; Zhang G; Xiang S; Jiang C; Chen Z; Li Y; Huang B; Zhou W; Lian Q; Wu B
    Front Behav Neurosci; 2021; 15():775209. PubMed ID: 34924971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of intracerebroventricular infusion of (+)-4-propyl-9-hydroxynapthoxacine (PHNO) through a totally implanted drug delivery system in rats with dopamine deficiency.
    de Yebenes JG; Fahn S; Jackson-Lewis V; Mena MA
    Mov Disord; 1987; 2(4):291-9. PubMed ID: 2904650
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Continuous intracerebroventricular infusion of dopamine and dopamine agonists through a totally implanted drug delivery system in animal models of Parkinson's disease.
    de Yebenes JG; Fahn S; Lovelle S; Jackson-Lewis V; Jorge P; Mena MA; Reiriz J; Bustos JC; Magariños C; Martinez A
    Mov Disord; 1987; 2(3):143-58. PubMed ID: 2904648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Continuous dopaminergic stimulation by pramipexole is effective to treat early morning akinesia in animal models of Parkinson's disease: A pharmacokinetic-pharmacodynamic study using in vivo microdialysis in rats.
    Ferger B; Buck K; Shimasaki M; Koros E; Voehringer P; Buerger E
    Synapse; 2010 Jul; 64(7):533-41. PubMed ID: 20196139
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
    Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
    Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dopamine stimulation via infusion in the lateral ventricle.
    Biagioni F; Busceti CL; Molinaro G; Battaglia G; Giorgi FS; Ruggieri S; Fornai F
    Ann N Y Acad Sci; 2006 Aug; 1074():337-43. PubMed ID: 17105930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of apomorphine in Parkinson's disease.
    Stocchi F
    Neurol Sci; 2008 Dec; 29 Suppl 5():S383-6. PubMed ID: 19381769
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.